Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Basal Ganglia Lesions”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT00001776
What this trial is testing

Effects of Brain Stimulation on Learning and Reasoning

Who this might be right for
Cerebellar DiseaseDementiaHealthy+1 more
National Institute of Neurological Disorders and Stroke (NINDS) 122
Not applicableEnded earlyNCT03052712
What this trial is testing

Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies

Who this might be right for
Alzheimer DiseaseParkinson DiseaseFrontal Dementia+3 more
Centre Hospitalier Universitaire, Amiens 44
Not applicableStudy completedNCT03300193
What this trial is testing

The Effect of Lesion Characteristics in MRgFUS on Tremor in Essential Tremor and Parkinson's Disease

Who this might be right for
Tremor
Rambam Health Care Campus 23
Post-approval studies (Phase 4)Study completedNCT01519271
What this trial is testing

Mild Cognitive Impairment in Parkinson's Disease

Who this might be right for
Parkinson's DiseaseMild Cognitive Impairment
University of Pennsylvania 28
Testing effectiveness (Phase 2)Study completedNCT06247410
What this trial is testing

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
SocraTec R&D GmbH 38
Large-scale testing (Phase 3)Study completedNCT00522379
What this trial is testing

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Who this might be right for
Parkinson's Disease
UCB Pharma 514
Testing effectiveness (Phase 2)Study completedNCT00001931
What this trial is testing

Treatment of Parkinson's Disease With a Transdermal Skin Patch

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableStudy completedNCT00169325
What this trial is testing

Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions

Who this might be right for
Basal Ganglia Lesions
Marie-laure Welter 11
Post-approval studies (Phase 4)Study completedNCT00594464
What this trial is testing

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

Who this might be right for
Parkinson's Disease
UCB Pharma 14
Not applicableStudy completedNCT02227355
What this trial is testing

Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
UCB Biopharma S.P.R.L. 195
Large-scale testing (Phase 3)Study completedNCT00243945
What this trial is testing

A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease

Who this might be right for
IDIOPATHIC PARKINSON'S DISEASE
UCB Pharma 58
Early research (Phase 1)Study completedNCT02230904
What this trial is testing

Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB BIOSCIENCES GmbH 57
Large-scale testing (Phase 3)Study completedNCT00767091
What this trial is testing

Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia

Who this might be right for
Parkinson's DiseaseApathyno Dementia
University Hospital, Lille 40
Not applicableStudy completedNCT02038608
What this trial is testing

Compensatory Mechanisms in Parkinson Disease (PD)

Who this might be right for
Parkinson's Disease
Hospices Civils de Lyon 49
Large-scale testing (Phase 3)Study completedNCT01646255
What this trial is testing

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma 346
Early research (Phase 1)Study completedNCT04384666
What this trial is testing

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers

Who this might be right for
Parkinson Disease
Luye Pharma Group Ltd. 56
Post-approval studies (Phase 4)UnknownNCT03098368
What this trial is testing

Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors

Who this might be right for
Nocturnal Hypokinesia
Chulalongkorn University 40
Large-scale testing (Phase 3)Study completedNCT01646268
What this trial is testing

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

Who this might be right for
IDIOPATHIC PARKINSON'S DISEASE
UCB Pharma 249
Early research (Phase 1)Study completedNCT03733561
What this trial is testing

Assess Pharmacokinetic Profiles of LY03003 and Neupro

Who this might be right for
Parkinson Disease
Luye Pharma Group Ltd. 40
Large-scale testing (Phase 3)Study completedNCT00505687
What this trial is testing

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma 186
Next Page